comparemela.com
Home
Live Updates
Pharnext Sa : Pharnext updates on the development program in China for PXT3003 in Charcot-Marie-Tooth disease type 1A (CMT1A) -September 28, 2023 at 02:35 am EDT : comparemela.com
Pharnext Sa : Pharnext updates on the development program in China for PXT3003 in Charcot-Marie-Tooth disease type 1A (CMT1A) -September 28, 2023 at 02:35 am EDT
PARIS, France, 28 September 2023, 08:30 am CET – Pharnext SA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high...
Related Keywords
Taiwan
,
China
,
United States
,
Israel
,
Macau
,
Canada
,
Paris
,
France General
,
France
,
Hong Kong
,
Chinese
,
Fabreguettes Leib
,
Hugo Brugi
,
Anne Charlotte Dudicourt
,
Financial Press Relations
,
Euronext Growth Stock Exchange
,
Drug Administration
,
Clinical Development Program
,
Chinese National Medical Products Administration
,
Pharnext Announces Strategic Partnership
,
Chinese Pharmaceutical Group
,
Genenet Pharmaceuticals Co Ltd
,
Tasly Pharmaceutical
,
Greater China
,
Mainland China
,
World Clinical Tiral
,
Unither United States
,
Announces Strategic Partnership
,
Leading Chinese Pharmaceutical
,
Granted Priority Review
,
China Food
,
Announces First Patient Enrolled
,
Pivotal Phase
,
Development Program
,
Charcot Marie Tooth Disease Type
,
Markets
,
comparemela.com © 2020. All Rights Reserved.